Sonia Maria Poli
Director/Board Member at DIMERIX LIMITED
Net worth: 85 381 $ as of 2024-04-29
Active connections
| Name | Gender | Age | Linked companies | Collaboration |
|---|---|---|---|---|
| Vincent Lawton | M | 75 | 15 years | |
| Ray Hill | M | 79 | 15 years | |
| Ian Hobson | M | 59 |
Dimerix Bioscience Pty Ltd.
 Dimerix Bioscience Pty Ltd. Medical DistributorsDistribution Services Dimerix Bioscience Pty Ltd. engages in the development and commercialization of drug therapies and drug discovery tools. It deals with clinical research organizations to progress its programs through clinical studies. It focuses on the clinical development of its therapeutic product DMX200 which is targeted to treat patients with chronic kidney disease. The company was founded by James Howard Williams on December 16, 2004 and is headquartered in Melbourne, Australia. | 6 years |
| Andrea Pfeifer | M | 66 | 21 years | |
| Nina Webster | M | - | 6 years | |
| Douglas Williams | M | 66 | 6 years | |
| Marc Martinell Pedemonte | M | - |
Minoryx Therapeutics SL
 Minoryx Therapeutics SL BiotechnologyHealth Technology Minoryx Therapeutics SL engages in the development of drugs for the orphan genetic diseases of the central nervous system. The company was founded by Marc Martinell, Joan Aymami, Nigel Ten Fleming and Xavier Barril in 2011 and is headquartered in Barcelona, Spain. | 13 years |
| Oliver Sol | M | 58 | 8 years | |
| Hamish George | M | - | 5 years | |
| Piergiorgio Donati | M | 54 | 6 years | |
| Christopher Roberts | M | 35 | 5 years | |
| Monika Bütler | M | 63 | 3 years | |
| Hugh Alsop | M | - | 7 years | |
| Robert Shepherd | M | - | 7 years | |
| Claude Nicaise | M | 71 |
Minoryx Therapeutics SL
Minoryx Therapeutics SL BiotechnologyHealth Technology Minoryx Therapeutics SL engages in the development of drugs for the orphan genetic diseases of the central nervous system. The company was founded by Marc Martinell, Joan Aymami, Nigel Ten Fleming and Xavier Barril in 2011 and is headquartered in Barcelona, Spain. | - |
| Monica Shaw | M | 46 | 3 years | |
| Jean-Fabien Monin | M | 54 | 15 years | |
| Werner Lanthaler | M | 56 | 6 years | |
| Carl June | M | 70 | 4 years | |
| Gary Waanders | M | 60 | - | |
| Roger G. Mills | M | 67 | 8 years | |
| Roy Ervin Twyman | M | 68 | 5 years | |
| Bojana Portmann | M | 43 | 13 years | |
| Mark Danton | M | 60 | 5 years | |
| Carole Nüchterlein | F | 62 |
F. Hoffmann-La Roche Ltd.
 F. Hoffmann-La Roche Ltd. Pharmaceuticals: MajorHealth Technology F. Hoffmann-La Roche Ltd. manufactures pharmaceutical products. It offers pharmaceutical drugs, pharmaceutical instruments, and diagnostics solutions. The company was founded by Fritz Hoffmann-La Roche on October 1, 1896 and is headquartered in Basel, Switzerland. | 22 years |
| Clinton Snow | M | - | 1 years | |
| Xavier Badia | M | - |
Minoryx Therapeutics SL
Minoryx Therapeutics SL BiotechnologyHealth Technology Minoryx Therapeutics SL engages in the development of drugs for the orphan genetic diseases of the central nervous system. The company was founded by Marc Martinell, Joan Aymami, Nigel Ten Fleming and Xavier Barril in 2011 and is headquartered in Barcelona, Spain. | - |
| Marc Engelen | M | - |
Minoryx Therapeutics SL
Minoryx Therapeutics SL BiotechnologyHealth Technology Minoryx Therapeutics SL engages in the development of drugs for the orphan genetic diseases of the central nervous system. The company was founded by Marc Martinell, Joan Aymami, Nigel Ten Fleming and Xavier Barril in 2011 and is headquartered in Barcelona, Spain. | - |
| Gerald Raymond | M | - |
Minoryx Therapeutics SL
Minoryx Therapeutics SL BiotechnologyHealth Technology Minoryx Therapeutics SL engages in the development of drugs for the orphan genetic diseases of the central nervous system. The company was founded by Marc Martinell, Joan Aymami, Nigel Ten Fleming and Xavier Barril in 2011 and is headquartered in Barcelona, Spain. | - |
| David Fuller | M | - | 1 years | |
| Howard Donovan | M | 49 | 2 years | |
| Julian Snow | M | - | - | |
| Sílvia Pascual | F | - |
Minoryx Therapeutics SL
Minoryx Therapeutics SL BiotechnologyHealth Technology Minoryx Therapeutics SL engages in the development of drugs for the orphan genetic diseases of the central nervous system. The company was founded by Marc Martinell, Joan Aymami, Nigel Ten Fleming and Xavier Barril in 2011 and is headquartered in Barcelona, Spain. | 9 years |
| Lénaic Teyssédou | M | 38 | 7 years | |
| Julien Rongère | M | 47 | 7 years | |
| Alexandre Caratsch | M | 59 | 6 years | |
| Pablo Cironi | M | - |
Minoryx Therapeutics SL
Minoryx Therapeutics SL BiotechnologyHealth Technology Minoryx Therapeutics SL engages in the development of drugs for the orphan genetic diseases of the central nervous system. The company was founded by Marc Martinell, Joan Aymami, Nigel Ten Fleming and Xavier Barril in 2011 and is headquartered in Barcelona, Spain. | 5 years |
| Thomas Tribelhorn | M | 54 |
F. Hoffmann-La Roche Ltd.
F. Hoffmann-La Roche Ltd. Pharmaceuticals: MajorHealth Technology F. Hoffmann-La Roche Ltd. manufactures pharmaceutical products. It offers pharmaceutical drugs, pharmaceutical instruments, and diagnostics solutions. The company was founded by Fritz Hoffmann-La Roche on October 1, 1896 and is headquartered in Basel, Switzerland. | 24 years |
| Carulla Tormo | M | - |
Minoryx Therapeutics SL
Minoryx Therapeutics SL BiotechnologyHealth Technology Minoryx Therapeutics SL engages in the development of drugs for the orphan genetic diseases of the central nervous system. The company was founded by Marc Martinell, Joan Aymami, Nigel Ten Fleming and Xavier Barril in 2011 and is headquartered in Barcelona, Spain. | 2 years |
| Khalid Islam | M | 67 |
Minoryx Therapeutics SL
Minoryx Therapeutics SL BiotechnologyHealth Technology Minoryx Therapeutics SL engages in the development of drugs for the orphan genetic diseases of the central nervous system. The company was founded by Marc Martinell, Joan Aymami, Nigel Ten Fleming and Xavier Barril in 2011 and is headquartered in Barcelona, Spain. | 8 years |
| Madiha Derouazi | M | 51 | - | |
| Karen Wagner | M | 54 |
Minoryx Therapeutics SL
Minoryx Therapeutics SL BiotechnologyHealth Technology Minoryx Therapeutics SL engages in the development of drugs for the orphan genetic diseases of the central nervous system. The company was founded by Marc Martinell, Joan Aymami, Nigel Ten Fleming and Xavier Barril in 2011 and is headquartered in Barcelona, Spain. | - |
| Philippe Monteyne | M | - |
Minoryx Therapeutics SL
Minoryx Therapeutics SL BiotechnologyHealth Technology Minoryx Therapeutics SL engages in the development of drugs for the orphan genetic diseases of the central nervous system. The company was founded by Marc Martinell, Joan Aymami, Nigel Ten Fleming and Xavier Barril in 2011 and is headquartered in Barcelona, Spain. | 6 years |
| Mark Diamond | M | - | 1 years | |
| Jordi Petit Salamo | M | - |
Minoryx Therapeutics SL
Minoryx Therapeutics SL BiotechnologyHealth Technology Minoryx Therapeutics SL engages in the development of drugs for the orphan genetic diseases of the central nervous system. The company was founded by Marc Martinell, Joan Aymami, Nigel Ten Fleming and Xavier Barril in 2011 and is headquartered in Barcelona, Spain. | - |
| Nuno Mendonça | M | 42 | 1 years |
Connections Chart
Multi-company connection
Former connections
| Name | Gender | Age | Linked companies | Collaboration |
|---|---|---|---|---|
| Howard Digby | M | 57 |
Dimerix Bioscience Pty Ltd.
Dimerix Bioscience Pty Ltd. Medical DistributorsDistribution Services Dimerix Bioscience Pty Ltd. engages in the development and commercialization of drug therapies and drug discovery tools. It deals with clinical research organizations to progress its programs through clinical studies. It focuses on the clinical development of its therapeutic product DMX200 which is targeted to treat patients with chronic kidney disease. The company was founded by James Howard Williams on December 16, 2004 and is headquartered in Melbourne, Australia. | 2 years |
| Bharatt Chowrira | M | 59 | 2 years | |
| David Franklyn | M | 60 |
Dimerix Bioscience Pty Ltd.
Dimerix Bioscience Pty Ltd. Medical DistributorsDistribution Services Dimerix Bioscience Pty Ltd. engages in the development and commercialization of drug therapies and drug discovery tools. It deals with clinical research organizations to progress its programs through clinical studies. It focuses on the clinical development of its therapeutic product DMX200 which is targeted to treat patients with chronic kidney disease. The company was founded by James Howard Williams on December 16, 2004 and is headquartered in Melbourne, Australia. | 4 years |
| Martin Velasco | M | 70 | 18 years | |
| Ulrich Winzenried | M | 69 |
F. Hoffmann-La Roche Ltd.
F. Hoffmann-La Roche Ltd. Pharmaceuticals: MajorHealth Technology F. Hoffmann-La Roche Ltd. manufactures pharmaceutical products. It offers pharmaceutical drugs, pharmaceutical instruments, and diagnostics solutions. The company was founded by Fritz Hoffmann-La Roche on October 1, 1896 and is headquartered in Basel, Switzerland. | - |
| Werner Henrich | M | 80 |
F. Hoffmann-La Roche Ltd.
F. Hoffmann-La Roche Ltd. Pharmaceuticals: MajorHealth Technology F. Hoffmann-La Roche Ltd. manufactures pharmaceutical products. It offers pharmaceutical drugs, pharmaceutical instruments, and diagnostics solutions. The company was founded by Fritz Hoffmann-La Roche on October 1, 1896 and is headquartered in Basel, Switzerland. | - |
| Bernhard Furrer | M | 52 |
F. Hoffmann-La Roche Ltd.
F. Hoffmann-La Roche Ltd. Pharmaceuticals: MajorHealth Technology F. Hoffmann-La Roche Ltd. manufactures pharmaceutical products. It offers pharmaceutical drugs, pharmaceutical instruments, and diagnostics solutions. The company was founded by Fritz Hoffmann-La Roche on October 1, 1896 and is headquartered in Basel, Switzerland. | - |
| Peter Bollmann | M | 71 | 6 years | |
| Alan Colowick | M | 61 | 2 years | |
| Kathy Harrison | F | - | 2 years | |
| Tatiana Pont Carteret | F | 58 | 4 years | |
| Krzysztof Dabrowski | M | 70 |
F. Hoffmann-La Roche Ltd.
F. Hoffmann-La Roche Ltd. Pharmaceuticals: MajorHealth Technology F. Hoffmann-La Roche Ltd. manufactures pharmaceutical products. It offers pharmaceutical drugs, pharmaceutical instruments, and diagnostics solutions. The company was founded by Fritz Hoffmann-La Roche on October 1, 1896 and is headquartered in Basel, Switzerland. | 7 years |
| Chris Maggos | M | 54 | - | |
| Thomas Graney | M | 60 | 7 years | |
| Peter Webse | M | 61 | 2 years | |
| Franz Humer | M | 76 |
F. Hoffmann-La Roche Ltd.
F. Hoffmann-La Roche Ltd. Pharmaceuticals: MajorHealth Technology F. Hoffmann-La Roche Ltd. manufactures pharmaceutical products. It offers pharmaceutical drugs, pharmaceutical instruments, and diagnostics solutions. The company was founded by Fritz Hoffmann-La Roche on October 1, 1896 and is headquartered in Basel, Switzerland. | 3 years |
| Zaborowski MaryJo | F | - |
F. Hoffmann-La Roche Ltd.
F. Hoffmann-La Roche Ltd. Pharmaceuticals: MajorHealth Technology F. Hoffmann-La Roche Ltd. manufactures pharmaceutical products. It offers pharmaceutical drugs, pharmaceutical instruments, and diagnostics solutions. The company was founded by Fritz Hoffmann-La Roche on October 1, 1896 and is headquartered in Basel, Switzerland. | 10 years |
| Mark Epping-Jordan | M | - | 6 years | |
| Andrew Galazka | M | 69 | 8 years | |
| Friedrich von Bohlen und Halbach | M | 60 | 5 years | |
| Carola Rita della Porta | F | 59 |
University of Milan
| 9 years |
| Monica Luisa Montironi | F | 54 |
University of Milan
| 3 years |
| Roberto Franzo | M | 59 |
University of Milan
| 3 years |
| Alessandra Stabilini | M | 53 |
University of Milan
| 3 years |
| Luigi Francesco Gozzini | M | 57 |
University of Milan
| 4 years |
| Ilaria Queirolo | M | - |
University of Milan
| 3 years |
| Ilaria Ambrosella Landonio | M | - |
University of Milan
| 3 years |
| Roberto Leonardi | M | - |
University of Milan
| 4 years |
| Daniele Conti | M | 60 |
University of Milan
| 4 years |
| Bibop Gresta | M | - |
University of Milan
| 2 years |
| Piergiuseppe Caldana | M | 60 |
University of Milan
| 4 years |
| Filippo Zanetti | M | - |
University of Milan
| 5 years |
| Massimiliano Picardi | M | 52 |
University of Milan
| 4 years |
| Ludovica Maria Vittoria Parodi Borgia | F | - |
University of Milan
| 3 years |
| Stefano Giordani | M | - |
University of Milan
| 4 years |
| Paola Margutti | F | 57 |
University of Milan
| 3 years |
| Paolo Lecchi | M | - |
University of Milan
| 3 years |
| Alberto Fioravanti | M | 62 |
University of Milan
| 9 years |
| Alessandra della Porta | F | 60 |
University of Milan
| 3 years |
| Paolo Orlando | M | 55 |
University of Milan
| 4 years |
| Annalisa Sara Doris | F | 54 |
University of Milan
| 4 years |
| Luca Emilio Magnoni | M | 54 |
University of Milan
| 4 years |
| Giasone Salati | M | 50 |
University of Milan
| 4 years |
| Nicolò Romani | M | 57 |
University of Milan
| 4 years |
| Barbara Masella | F | 59 |
University of Milan
| 4 years |
| Marco Romano | M | - |
University of Milan
| 1 years |
| Annapaola Negri-Clementi | F | 53 |
University of Milan
| 3 years |
| Paola Sala | F | 58 |
University of Milan
| 3 years |
| Francesca Rasetti | M | 58 |
University of Milan
| 4 years |
| Andrea Zaglio | M | 57 |
University of Milan
| 1 years |
| Simone Andrea Crolla | M | - |
University of Milan
| 4 years |
| Marco Guerra | M | - |
University of Milan
| 4 years |
| Elena Angela Carpani | F | 56 |
University of Milan
| 4 years |
| Stefano Gardi | M | - |
University of Milan
| 6 years |
Statistics
| Country | Connections | % of total |
|---|---|---|
| Switzerland | 42 | 42.00% |
| Italy | 34 | 34.00% |
| Australia | 12 | 12.00% |
| Spain | 12 | 12.00% |
Age of Connections
Active
Past
Male
Female
Members of the board
Executives
Origin of connections
- Stock Market
- Insiders
- Sonia Maria Poli
- Personal Network
